HK1065257A1 - Medicinal composition - Google Patents
Medicinal compositionInfo
- Publication number
- HK1065257A1 HK1065257A1 HK04108103A HK04108103A HK1065257A1 HK 1065257 A1 HK1065257 A1 HK 1065257A1 HK 04108103 A HK04108103 A HK 04108103A HK 04108103 A HK04108103 A HK 04108103A HK 1065257 A1 HK1065257 A1 HK 1065257A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicinal composition
- medicinal
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001156815 | 2001-05-25 | ||
JP2001319075A JP4310605B2 (ja) | 2001-05-25 | 2001-10-17 | 医薬用組成物 |
PCT/JP2002/004979 WO2002096466A1 (en) | 2001-05-25 | 2002-05-23 | Medicinal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1065257A1 true HK1065257A1 (en) | 2005-02-18 |
Family
ID=26615705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04108103A HK1065257A1 (en) | 2001-05-25 | 2004-10-18 | Medicinal composition |
Country Status (11)
Country | Link |
---|---|
US (1) | US8703189B2 (xx) |
EP (1) | EP1398040A4 (xx) |
JP (1) | JP4310605B2 (xx) |
KR (1) | KR100943347B1 (xx) |
CN (1) | CN100404071C (xx) |
AU (1) | AU2002258221B2 (xx) |
CA (1) | CA2445388C (xx) |
HK (1) | HK1065257A1 (xx) |
MX (1) | MXPA03010742A (xx) |
TW (1) | TWI293883B (xx) |
WO (1) | WO2002096466A1 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8734843B2 (en) * | 2003-06-27 | 2014-05-27 | Otsuka Pharmaceutical Co., Ltd. | Medicament sustained-release particles and method for preparing the same |
EP1830886B1 (en) | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
CA2545658A1 (en) * | 2005-11-08 | 2007-05-08 | Accelis Formulations Ltd. | Compositions and methods for weight-loss and weight-loss maintenance in daytime and nighttime formulation |
ZA200805793B (en) * | 2005-12-22 | 2009-11-25 | Otsuka Pharma Co Ltd | Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
KR101697833B1 (ko) * | 2005-12-22 | 2017-01-18 | 오츠카 세이야쿠 가부시키가이샤 | 약물 함유 왁스 매트릭스 입자의 제조 방법, 상기 방법에 사용되는 익스트루더, 및 실로스타졸을 함유하는 서방성 제제 |
EP1880714A1 (en) * | 2006-07-20 | 2008-01-23 | Helm AG | Amorphous Aripiprazole and Process for the Preparation thereof |
EP2082735B1 (en) | 2008-01-23 | 2010-09-29 | Helm AG | Amorphous Aripiprazole and Process for the Preparation thereof |
US7799790B2 (en) | 2006-07-20 | 2010-09-21 | Helm Ag | Amorphous aripiprazole and process for the preparation thereof |
KR20080076382A (ko) * | 2007-02-15 | 2008-08-20 | (주)아모레퍼시픽 | 실로스타졸의 제어방출 제제 및 그 제조방법 |
AU2008258596B2 (en) | 2007-06-04 | 2013-02-14 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
NZ594207A (en) | 2009-02-06 | 2013-03-28 | Egalet Ltd | Immediate release composition resistant to abuse by intake of alcohol |
EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
TR201000948A1 (tr) | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazol formülasyonları. |
KR101182114B1 (ko) * | 2010-03-05 | 2012-09-12 | 한림제약(주) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
WO2014014010A1 (ja) | 2012-07-20 | 2014-01-23 | 大塚製薬株式会社 | 表面にインクの乾燥皮膜を有する錠剤、及びインクジェットプリンタ用インク |
EP3897731A1 (en) * | 2018-12-18 | 2021-10-27 | DDP Specialty Electronic Materials US, Inc. | A sustained release composition comprising an ethylcellulose |
JPWO2020213589A1 (xx) * | 2019-04-15 | 2020-10-22 | ||
JPWO2021182467A1 (xx) * | 2020-03-11 | 2021-09-16 | ||
CN112516105A (zh) * | 2020-12-10 | 2021-03-19 | 成都恒瑞制药有限公司 | 一种氯沙坦钾口服制剂及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
JP2893191B2 (ja) * | 1988-11-08 | 1999-05-17 | 武田薬品工業株式会社 | 放出制御性マトリックス剤 |
AU645003B2 (en) | 1988-11-08 | 1994-01-06 | Takeda Chemical Industries Ltd. | Sustained release preparations |
IL92343A0 (en) * | 1988-12-20 | 1990-07-26 | Gist Brocades Nv | Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them |
JP3130058B2 (ja) | 1991-02-15 | 2001-01-31 | 第一製薬株式会社 | マスクされた粒状物 |
ES2194863T3 (es) * | 1992-11-30 | 2003-12-01 | Kv Pharm Co | Materiales farmaceuticos con enmascarado de sabor. |
US5656291A (en) * | 1994-03-16 | 1997-08-12 | Pharmacia & Upjohn Aktiebolag | Controlled release preparation |
JP3247511B2 (ja) | 1993-09-07 | 2002-01-15 | 山之内製薬株式会社 | 医薬用組成物 |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
JPH08143450A (ja) | 1994-11-14 | 1996-06-04 | Taiyo Yakuhin Kogyo Kk | 徐放化製剤 |
ES2210321T3 (es) * | 1994-12-19 | 2004-07-01 | Daiichi Pharmaceutical Co., Ltd. | Preparacion granular de liberacion prolongada y procedimiento de produccion. |
DE19504831A1 (de) * | 1995-02-14 | 1996-09-05 | Basf Ag | Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose |
ATE283038T1 (de) | 1995-07-21 | 2004-12-15 | Daiichi Seiyaku Co | Verfahren zu herstellung einer granulären zubereitung |
ATE240734T1 (de) * | 1995-07-26 | 2003-06-15 | Kyowa Hakko Kogyo Kk | Zubereitung von xanthinderivaten als feste dispersion |
WO1998042323A1 (en) | 1997-03-25 | 1998-10-01 | Takeda Chemical Industries, Ltd. | Stabilized urease inhibitor |
PT1009387E (pt) | 1997-07-02 | 2006-08-31 | Euro Celtique Sa | Formulacoes estabilizadas de libertacao controlada de tramadol |
JP3611456B2 (ja) | 1997-09-30 | 2005-01-19 | 日研化学株式会社 | テオフィリン徐放性錠剤 |
DK1037607T3 (da) | 1997-12-08 | 2004-06-21 | Altana Pharma Ag | Hidtil ukendt suppositoriumsform, der omfatter en syrelabil aktiv forbindelse |
WO2000018372A1 (fr) * | 1998-09-30 | 2000-04-06 | Taisho Pharmaceutical Co., Ltd. | Granules pour preparations orales |
JP2000169364A (ja) * | 1998-09-30 | 2000-06-20 | Taisho Pharmaceut Co Ltd | 経口製剤用粒子 |
CN1361683A (zh) * | 1999-06-07 | 2002-07-31 | 比克·古尔顿·劳姆贝尔格化学公司 | 含有一种对酸不稳定的活性化合物的新型制剂和药物剂型 |
-
2001
- 2001-10-17 JP JP2001319075A patent/JP4310605B2/ja not_active Expired - Fee Related
-
2002
- 2002-05-23 CA CA2445388A patent/CA2445388C/en not_active Expired - Fee Related
- 2002-05-23 US US10/477,427 patent/US8703189B2/en not_active Expired - Fee Related
- 2002-05-23 CN CNB028099648A patent/CN100404071C/zh not_active Expired - Fee Related
- 2002-05-23 EP EP02728121A patent/EP1398040A4/en not_active Withdrawn
- 2002-05-23 MX MXPA03010742A patent/MXPA03010742A/es active IP Right Grant
- 2002-05-23 WO PCT/JP2002/004979 patent/WO2002096466A1/ja active Application Filing
- 2002-05-23 AU AU2002258221A patent/AU2002258221B2/en not_active Ceased
- 2002-05-23 KR KR1020037015237A patent/KR100943347B1/ko not_active IP Right Cessation
- 2002-05-24 TW TW091111129A patent/TWI293883B/zh not_active IP Right Cessation
-
2004
- 2004-10-18 HK HK04108103A patent/HK1065257A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2003040764A (ja) | 2003-02-13 |
CA2445388C (en) | 2010-07-13 |
CN1509185A (zh) | 2004-06-30 |
EP1398040A1 (en) | 2004-03-17 |
KR20040004641A (ko) | 2004-01-13 |
KR100943347B1 (ko) | 2010-02-22 |
CA2445388A1 (en) | 2002-12-05 |
CN100404071C (zh) | 2008-07-23 |
TWI293883B (en) | 2008-03-01 |
MXPA03010742A (es) | 2004-03-02 |
US20040175422A1 (en) | 2004-09-09 |
EP1398040A4 (en) | 2011-03-02 |
AU2002258221B2 (en) | 2007-08-23 |
WO2002096466A1 (en) | 2002-12-05 |
US8703189B2 (en) | 2014-04-22 |
JP4310605B2 (ja) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1450824A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP1407785A4 (en) | MEDICAL COMPOSITIONS | |
HK1065944A1 (en) | Medicinal compositions | |
HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
GB0111597D0 (en) | Pharmaceutical compositions | |
HUP0303163A3 (en) | Tramadol-based pharmaceutical composition | |
GB0117057D0 (en) | Pharmaceutical composition | |
HK1065257A1 (en) | Medicinal composition | |
AU2002258221A1 (en) | Medicinal composition | |
EP1408896A4 (en) | PHARMACEUTICAL COMPOSITION | |
HK1057474A1 (en) | Medicinal composition | |
GB0129117D0 (en) | Pharmaceutical composition | |
GB0116107D0 (en) | Pharmaceutical composition | |
GB0127805D0 (en) | Pharmaceutical composition | |
PL370037A1 (en) | Pharmaceutical composition | |
GB0104752D0 (en) | Pharmaceutical compositions | |
GB0124710D0 (en) | Therapeutic composition | |
GB0114746D0 (en) | Medicinal composition | |
AU2002354460A1 (en) | Medicinal composition | |
GB2382302B (en) | Pharmaceutical compositions | |
GB0005382D0 (en) | Pharmaceutical composition | |
IL157411A0 (en) | Pharmaceutical composition | |
EP1413314A4 (en) | MEDICAL COMPOSITIONS | |
GB0125061D0 (en) | Pharmaceutical composition | |
HU0103049D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160523 |